<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR26">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Phillips</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mistry</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Riva</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Cooksley</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Hadzhiolova-Lebeau</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Plavova</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Katzarov</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Simonova</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zeuzem</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Woffendin</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients</article-title>
  <source>Front Immunol</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>621</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2017.00621</pub-id>
  <?supplied-pmid 5446997?>
  <pub-id pub-id-type="pmid">28611778</pub-id>
 </element-citation>
</ref>
